Trial intelligence / Profile preview

REVIVE-RP: Avanafil for ED post-prostatectomy

NCT00895011Phase 3Completed

Sponsor
VIVUS
Start
Apr 2009
Primary completion
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of avanafil in erectile dysfunction (ED), sponsored by VIVUS. Started Apr 2009; status: completed.

02

Drugs

avanafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00895011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00895011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call